Daily as of 2 Nov 16:00 ET
- Price
- below both $19.42 vs 50 $25.43 / 200 $21.21
- Projection
- 💀Death cross estimated in 16 to 24 bars
- Test
- No active test
- Last cross
- 🟨Golden cross 26 May 2026 · projected 15 bars out
CUE | Cue BiopharmaNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history
$19.42
-$1.45 (-6.95%)
Cue Biopharma (CUE) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2019.
Right now the daily is the chart to watch. The 50 SMA has sat above the 200 since May 2026, but the two have been closing on each other and a death cross is projected within 30 bars. On both the daily and the 4-hour, price sits below the 50 and the 200; on the weekly it is between the two.
Timeframe summary
Weekly as of 30 Oct 16:00 ET
- Price
- between the two $20.87 vs 50 $20.08 / 200 $47.44
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 💀Death cross week of 31 Jan 2022 · projected 12 bars out
4-hour as of 3 Nov 16:00 ET
- Price
- below both $20.86 vs 50 $21.10 / 200 $27.20
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 💀Death cross 14 Oct 2026 · projected 21 bars out
Cross history
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 14 Oct 2026 | 💀Death | 4-hour | 21 bars out | Not tested |
| 26 May 2026 | 🟨Golden moderate | daily | 15 bars out | Not tested |
| 22 Apr 2026 | 🟨Golden | 4-hour | 25 bars out | 2 bar cross test |
| 7 Nov 2025 | 💀Death | 4-hour | 18 bars out | Not tested |
| 24 Oct 2025 | 🟨Golden | 4-hour | 16 bars out | 3 bar cross test |
About CUE
ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$4.4M
4-hour coverageYes, since Oct 2025
History on recordSince 2019
SectorHealthcare
Cap bandmicro